Literature DB >> 2550492

Effects of bombesin on human small cell lung cancer cells: evidence for a subset of bombesin non-responsive cell lines.

H Kado-Fong1, B Malfroy.   

Abstract

The effects of bombesin on three human small cell lung carcinoma cell (SCLC) lines (NCI-H69, NCI-H128, and NCI-H345) have been examined and compared to the effects of the peptide on the mouse fibroblast cell line Swiss 3T3, and the rat pituitary tumor cell line GH3W5. While all three SCLC lines expressed messenger RNA encoding pro-gastrin releasing peptide (GRP), only the NCI-H345 cells expressed detectable membrane receptors for GRP and responded to nanomolar concentrations of bombesin as shown by 125I-GRP binding, total inositol phosphate accumulation, and increased clonal growth in soft agarose. These data show that some SCLC lines are insensitive to bombesin and do not express detectable membrane receptors for GRP.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550492     DOI: 10.1002/jcb.240400404

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  5 in total

1.  Characterization of ligand binding and processing by gastrin-releasing peptide receptors in a small-cell lung cancer cell line.

Authors:  C Cardona; N M Bleehen; J G Reeve
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

Review 2.  Neuropeptide growth factors and cancer.

Authors:  P J Woll
Journal:  Br J Cancer       Date:  1991-03       Impact factor: 7.640

3.  Bombesin stimulates proliferation of human breast cancer cells in culture.

Authors:  J Nelson; M Donnelly; B Walker; J Gray; C Shaw; R F Murphy
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

4.  [Arg6,D-Trp7,9,NmePhe8]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism.

Authors:  A C MacKinnon; R A Armstrong; C M Waters; J Cummings; J F Smyth; C Haslett; T Sethi
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

5.  Breast cancer cell-associated endopeptidase EC 24.11 modulates proliferative response to bombesin.

Authors:  D M Burns; B Walker; J Gray; J Nelson
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.